PANK2 and pantothenate kinase-associated neurodegeneration: For example, experimental treatments are currently being explored in trials for Pantothenate kinase 2-associated neurodegeneration (PKAN, also known as Hallervorden-Spatz disease), such as gene therapy, chelation with Deferiprone [30] to prevent neurodegeneration caused by brain iron accumulation.